Fábio Franciscatto Stieven

Fábio Franciscatto Stieven

Auto-generated profile, based on publicly available information

Fábio Franciscatto Stieven

Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Journal of Physiotherapy
Verified
Journal Article
Open access
GFGiovanni Ferreira
Giovanni Ferreira
FSFábio Stieven
Fábio Stieven
FAFrancisco Xavier de Araujo
Francisco Xavier de Araujo
MWMatheus Wiebusch
Matheus Wiebusch
CRCarolina Rosa
Carolina Rosa
MSMarcelo Silva
Marcelo Silva
In people with nerve-related leg pain, does adding neurodynamic treatment to advice to remain active improve leg pain, disability, low back pain, function, global perceived effect and location of symptoms? Randomised trial with concealed allocation and intention-to-treat analysis. Sixty participants with nerve-related leg pain recruited from the community. The experimental group received four sessions of neurodynamic treatment. Both groups received advice to remain active. Leg pain and low back pain (0, none, to 10, worst), Oswestry Disability Index (0, none, to 100, worst), Patient-Specific Functional Scale (0, unable to perform, to 30, able to perform), global perceived effect (-5 to 5) and location of symptoms were measured at 2 and 4 weeks after randomisation. Continuous outcomes were analysed by linear mixed models. Location of symptoms was assessed by relative risk (95% CI). At 2 weeks, the experimental group did not have significantly greater improvement than the control group in leg pain (MD -1.1, 95% CI -2.3 to 0.1) or disability (MD -3.3, 95% CI -9.6 to 2.9). At 4 weeks, the experimental group experienced a significantly greater reduction in leg pain (MD -2.4, 95% CI -3.6 to -1.2) and low back pain (MD -1.5, 95% CI -2.8 to -0.2). The experimental group also improved significantly more in function at 2 weeks (MD 5.2, 95% CI 2.2 to 8.2) and 4 weeks (MD 4.7, 95% CI 1.7 to 7.8), as well as global perceived effect at 2 weeks (MD 2.5, 95% CI 1.6 to 3.5) and 4 weeks (MD 2.9, 95% CI 1.9 to 3.9). No significant between-group differences occurred in disability at 4 weeks and location of symptoms. Adding neurodynamic treatment to advice to remain active did not improve leg pain and disability at 2 weeks. NCT01954199. [Ferreira G, Stieven F, Araujo F, Wiebusch M, Rosa C, Plentz R, et al. (2016) Neurodynamic treatment did not improve pain and disability at two weeks in patients with chronic nerve-related leg pain: a randomised trial.Journal of Physiotherapy62: 197-202].

1 October 2016 in Journal of Bodywork and Movement Therapies
Verified
Journal Article
Closed access
GFGiovanni E. Ferreira
Giovanni E. Ferreira
FSFábio F. Stieven
Fábio F. Stieven
FAFrancisco Xavier de Araujo
Francisco Xavier de Araujo
MWMatheus Wiebusch
Matheus Wiebusch
CRCarolina G. Rosa
Carolina G. Rosa
MSMarcelo F. Silva
Marcelo F. Silva

1 December 2013 in Manual Therapy
Verified
Journal Article
Closed access
FSFábio Franciscatto Stieven
Fábio Franciscatto Stieven
GFGiovanni Esteves Ferreira
Giovanni Esteves Ferreira
MSMarcelo Faria Silva
Marcelo Faria Silva
LRLuis Henrique Telles da Rosa
Luis Henrique Telles da Rosa

14 December 2016 in Journal of Physiotherapy
Verified
Journal Article
Open access
PDF file
GFGiovanni Ferreira
Giovanni Ferreira
FSFábio Stieven
Fábio Stieven
FAFrancisco Xavier de Araujo
Francisco Xavier de Araujo
MWMatheus Wiebusch
Matheus Wiebusch
CRCarolina Rosa
Carolina Rosa
MSMarcelo Silva
Marcelo Silva
We would like to thank the editor-in-chief of Journal of Physiotherapy for the opportunity to address Hall and colleagues’ concerns about our randomised trial of neurodynamic treatment for chronic nerve-related leg pain.1 Hall and colleagues stated that: the reporting of our results, emphasising the findings of the primary outcomes, has led to a binary and oversimplified conclusion that neurodynamic treatment ‘does not work’ despite the findings of some secondary outcomes; the choice of leg pain and disability as primary outcomes only at 2 weeks, but not at 4 weeks also, was illogical; the selection of the intermediate follow-up (4 weeks) as the primary outcome would have been more adequate than the short-term follow-up that we chose; and we should have considered using the Patient-Specific Functional Scale (PSFS) rather than the Oswestry Disability Index (ODI) as one of the primary outcomes.

31 December 2011 in Clinical Chiropractic
Verified
Journal Article
Closed access
FSFabio Stieven
Fabio Stieven
JTJaqueline Trierweiler
Jaqueline Trierweiler
DLDouglas Lenz
Douglas Lenz
GGGunther Gehlen
Gunther Gehlen

1 March 2016 in Physiotherapy
Verified
Journal Article
Closed access
FSFábio Franciscatto Stieven
Fábio Franciscatto Stieven
CSClaudia F. Gomes da Silva
Claudia F. Gomes da Silva
FGFelippe Guariglia
Felippe Guariglia
LTLuis Henrique da Rosa Telles
Luis Henrique da Rosa Telles
MSMarcelo F. Silva
Marcelo F. Silva